Literature DB >> 19184001

Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.

Thomas Josef Vogl1, Thaddäus T Wissniowski, Nagy N N Naguib, Renate M Hammerstingl, Martin G Mack, Sabine Münch, Matthias Ocker, Deike Strobel, Eckhart G Hahn, Johannes Hänsler.   

Abstract

PURPOSE: To asses if laser-induced thermotherapy (LITT) induces a specific cytotoxic T cell response in patients treated with LITT for colorectal cancer liver metastases.
METHODS: Eleven patients with liver metastases of colorectal cancer underwent LITT. Blood was sampled before and after LITT. Peripheral T cell activation was assessed by an interferon gamma (IFNg) secretion assay and flow cytometry. Test antigens were autologous liver and tumor lysate obtained from each patient by biopsy. T cells were stained for CD3/CD4/CD8 and IFNg to detect activated T cells. The ratio of IFNg positive to IFNg negative T cells was determined as the stimulation index (SI). To assess cytolytic activity, T cells were co-incubated with human colorectal cancer cells (CaCo) and cytosolic adenylate kinase release was measured by a luciferase assay.
RESULTS: IFNg secretion assay: before LITT SI was 12.73 (+/-4.83) for CD3+, 4.36 (+/-3.32) for CD4+ and 3.64 (+/-1.77) for CD8+ T cells against autologous tumor tissue. Four weeks after LITT SI had increased to 92.09 (+/-12.04) for CD3+ (P < 0.001), 42.92 (+/-16.68) for CD4+ (P < 0.001) and 47.54 (+/-15.68) for CD8+ T cells (P < 0.001) against autologous tumor tissue. No increased SI was observed with normal liver tissue at any time point. Cytotoxicity assay: before LITT activity against the respective cancer cells was low, with RLU = 1,493 (+/-1,954.68), whereas after LITT cytolytic activity had increased to RLU = 7,260 [+/-3,929.76 (P < 0.001)].
CONCLUSION: Patients with liver metastases of colorectal cancer show a tumor-specific cytotoxic T cell stimulation and a significantly increased cytolytic activity of CD3+, CD4+ and CD8+ T cells after LITT against an allogenic tumor (CaCo cell line).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184001     DOI: 10.1007/s00262-009-0663-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

Review 1.  Postablation Immune Microenvironment: Synergy between Interventional Oncology and Immuno-oncology.

Authors:  DaeHee Kim; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 2.  Role of Interventional Radiology in Pediatric Cancer Patients.

Authors:  Allison Aguado
Journal:  Curr Oncol Rep       Date:  2022-09-03       Impact factor: 5.945

Review 3.  Systematic review of ablation techniques for the treatment of malignant or aggressive benign lesions in children.

Authors:  Fernando M Gómez; Premal A Patel; Samuel Stuart; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2014-05-13

4.  Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Joshua Stopek; Efstratios Kosmidis; Thomas Vogl; Bernd Linsmeier; Kosmas Tsakiridis; Sofia Lampaki; George Lazaridis; Andreas Mpakas; Robert Browning; Antonis Papaiwannou; Antonis Drevelegas; Sofia Baka; Vasilis Karavasilis; Ioannis Mpoukovinas; J Francis Turner; Konstantinos Zarogoulidis; Johannes Brachmann
Journal:  J Cancer       Date:  2015-01-16       Impact factor: 4.207

5.  A Strategy for Precise Treatment of Cardiac Malignant Neoplasms.

Authors:  Wenshuo Wang; Jinqiang Shen; Hongyue Tao; Yun Zhao; Hui Nian; Lai Wei; Xiaoyuan Ling; Ye Yang; Limin Xia
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

6.  Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro.

Authors:  Tamara Polajzer; Tomaz Jarm; Damijan Miklavcic
Journal:  Radiol Oncol       Date:  2020-07-29       Impact factor: 2.991

Review 7.  Local Destruction of Tumors and Systemic Immune Effects.

Authors:  Karl-Göran Tranberg
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

8.  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Kaid Darwiche; Thomas Vogl; Eugene P Goldberg; Haidong Huang; Michael Simoff; Qiang Li; Robert Browning; Francis J Turner; Patrick Le Pivert; Dionysios Spyratos; Konstantinos Zarogoulidis; Seyhan I Celikoglu; Firuz Celikoglu; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-18       Impact factor: 4.162

Review 9.  The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment.

Authors:  Natasja L de Vries; Marloes Swets; Alexander L Vahrmeijer; Marianne Hokland; Peter J K Kuppen
Journal:  Int J Mol Sci       Date:  2016-06-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.